This site is intended for healthcare professionals
Abstract digital waveforms in blue and purple
FDA Drug information

Azathioprine

Read time: 1 mins
Marketing start date: 12 Nov 2024

Summary of product characteristics


Effective Time

20220805

Version

5

Spl Product Data Elements

Azathioprine Azathioprine AZATHIOPRINE AZATHIOPRINE CROSCARMELLOSE SODIUM LACTOSE MONOHYDRATE MAGNESIUM STEARATE POVIDONE STARCH, CORN YELLOW ROUND ZD;11 Azathioprine Azathioprine AZATHIOPRINE AZATHIOPRINE CROSCARMELLOSE SODIUM LACTOSE MONOHYDRATE MAGNESIUM STEARATE POVIDONE STARCH, CORN YELLOW ROUND ZD;10 Azathioprine Azathioprine AZATHIOPRINE AZATHIOPRINE CROSCARMELLOSE SODIUM LACTOSE MONOHYDRATE MAGNESIUM STEARATE POVIDONE STARCH, CORN YELLOW ROUND ZD;09

Application Number

ANDA077621

Brand Name

Azathioprine

Generic Name

Azathioprine

Product Ndc

70771-1139

Product Type

HUMAN PRESCRIPTION DRUG

Route

ORAL

Package Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 70771-1140-1 in bottle of 100 tablets Azathioprine Tablets USP, 75 mg 100 tablets Rx only 75 mg label 75 mg label

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.